HK1042241A1 - 膠囊系統 - Google Patents

膠囊系統 Download PDF

Info

Publication number
HK1042241A1
HK1042241A1 HK02103939.6A HK02103939A HK1042241A1 HK 1042241 A1 HK1042241 A1 HK 1042241A1 HK 02103939 A HK02103939 A HK 02103939A HK 1042241 A1 HK1042241 A1 HK 1042241A1
Authority
HK
Hong Kong
Prior art keywords
active agent
vehicle
gastrointestinal tract
emulsifier
capsule system
Prior art date
Application number
HK02103939.6A
Other languages
English (en)
Chinese (zh)
Inventor
A. Firestone Bruce
T. Tran Thao
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Publication of HK1042241A1 publication Critical patent/HK1042241A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02103939.6A 1999-03-04 2000-03-03 膠囊系統 HK1042241A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/262,623 US6248354B1 (en) 1999-03-04 1999-03-04 Capsule system
US09/262,623 1999-03-04
PCT/US2000/005811 WO2000051571A2 (en) 1999-03-04 2000-03-03 Capsule system

Publications (1)

Publication Number Publication Date
HK1042241A1 true HK1042241A1 (zh) 2002-08-09

Family

ID=22998308

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103939.6A HK1042241A1 (zh) 1999-03-04 2000-03-03 膠囊系統

Country Status (7)

Country Link
US (3) US6248354B1 (https=)
EP (1) EP1158965A2 (https=)
JP (1) JP2002538098A (https=)
AU (1) AU768796B2 (https=)
CA (1) CA2363933C (https=)
HK (1) HK1042241A1 (https=)
WO (1) WO2000051571A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US7115277B2 (en) * 1999-03-04 2006-10-03 Allergan, Inc. Method for enabling delivery of an active agent
US6457471B1 (en) 2000-06-30 2002-10-01 Medihale Ltd. Dual-purpose medical device for upper airway treatment and methods for using same
KR100560092B1 (ko) * 2000-12-15 2006-03-10 파트릭 프랑케 저알레르기성 및 비자극성 피부 보호 제제
US6752953B2 (en) * 2001-12-03 2004-06-22 Yung Shin Pharmaceutical Co., Ltd. Method for manufacturing hard non-gelatin pharmaceutical capsules
EP1547588B1 (en) * 2002-08-20 2013-12-11 Kowa Company, Ltd. Soft capsule preparation
EP1527774A1 (en) * 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
US20050026958A1 (en) * 2003-07-30 2005-02-03 Allergan, Inc. Methods of therapeutic treatment using amounts of retinoid components
US20050026950A1 (en) * 2003-07-30 2005-02-03 Allergan, Inc. Methods of therapeutic treatment using retinoids to achieve consistent bioavailability
CA2534008A1 (en) * 2003-07-30 2005-02-10 Allergan, Inc. Methods of therapeutic treatment using amounts of retinoid components
US20050026949A1 (en) * 2003-07-30 2005-02-03 Allergan, Inc. Methods of therapeutic treatment using amounts of retinoids without regard to body weight
US20060020037A1 (en) * 2004-07-22 2006-01-26 Allergan, Inc. Tazarotenic acid and esters thereof for treating autism
US20060234948A1 (en) * 2005-04-04 2006-10-19 Empie Mark W Lignan-containing compositions
US20070060620A1 (en) * 2005-09-09 2007-03-15 John Sefton Use of RAR retinoid agonists to increase sperm count and sperm mobility in males
CN102438590B (zh) * 2009-02-25 2013-07-10 施泰福研究澳大利亚有限公司 局部泡沫组合物
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
EP3006021A1 (en) 2009-05-20 2016-04-13 Ranbaxy Laboratories Limited Topical retinoid solutions
GB2488788B (en) * 2011-03-07 2013-07-10 Natco Pharma Ltd Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response
BR112014032948A2 (pt) * 2012-07-02 2017-06-27 Dsm Ip Assets Bv cápsulas contendo timoquinona
JP7728653B2 (ja) * 2021-04-05 2025-08-25 真 小林 内視鏡用処置具

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2960M (fr) * 1962-03-30 1964-11-30 Pfizer & Co C Compositions, facilement dispersibles dans l'eau, a base d'ester d'acide gras de vitamine a.
JPS58128141A (ja) * 1982-01-26 1983-07-30 Sumitomo Chem Co Ltd 自己乳化分散型カロチノイド類含有ソフトカプセル剤の製法
US4612194A (en) 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
CA1282326C (en) 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
JPH0426670A (ja) * 1990-05-18 1992-01-29 Nisshin Flour Milling Co Ltd 安定化された油溶性ビタミン含有組成物
JPH11504028A (ja) * 1995-04-24 1999-04-06 イースム リサーチ ディベロップメント カンパニー オブ ザ ヒーブル ユニバーシティ オブ エルサレム 油／水エマルジョンを作り出す自己乳化性配合物
EP0799616A1 (en) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Oral composition comprising a fumagillol derivative
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system

Also Published As

Publication number Publication date
EP1158965A2 (en) 2001-12-05
WO2000051571A2 (en) 2000-09-08
CA2363933C (en) 2006-07-11
WO2000051571B1 (en) 2001-05-25
JP2002538098A (ja) 2002-11-12
US20010016206A1 (en) 2001-08-23
CA2363933A1 (en) 2000-09-08
WO2000051571A3 (en) 2001-02-15
AU768796B2 (en) 2004-01-08
AU3726600A (en) 2000-09-21
US20040115257A1 (en) 2004-06-17
US6248354B1 (en) 2001-06-19
US6656500B2 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
WO2000051571A3 (en) Capsule system
WO2002002085A3 (de) Schnell zerfallende darreichungsform zur freisetzung von wirkstoffen im mundraum oder in körperhöhlen
AU1227899A (en) Osmotic medicament releasing system
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
CA2272586A1 (en) Rapidly disintegrable pharmaceutical composition
CA2337046A1 (en) Sustained release pharmaceutical preparation
CA2362728A1 (en) Improved aqueous solubility pharmaceutical formulations
CA2333869A1 (en) Mousse composition
CA2365826A1 (en) Over-coated chewing gum formulations
GB9223144D0 (en) Controlled release device
NZ302741A (en) Mucoadhesive carbomer granules for gastric medication
CA2197941A1 (en) A pharmaceutical tablet characterized by a showing high volume increase when coming into contact with biological fluids
EP1287822A3 (en) Mesalazine controlled release oral pharmaceutical compositions
NZ336691A (en) Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract
CA2377916A1 (en) Taste masked pharmaceutical liquid formulations
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
HK1043948A1 (zh) 一種用於在體腔內傳遞流動液體的一次性器具
CA2420461A1 (en) Preparations for oral administration
WO1998038983A3 (en) Swallow tablet comprising paracetamol
CA2256751A1 (fr) Comprime enrobe a base de maleate de trimebutine
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
FI20000780A7 (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
WO2001034118A3 (en) Solid dispersion pharmaceutical formulations
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
WO2001089317A3 (en) Dietary aids and methods of use thereof